Ovid Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ovid Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Ovid Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $92.6M, a 25.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $92.6M +$18.9M +25.7% Dec 31, 2023 10-K 2024-03-08
Q4 2022 $73.7M +$10.4M +16.4% Dec 31, 2022 10-K 2024-03-08
Q4 2021 $63.3M -$26.5M -29.5% Dec 31, 2021 10-K 2023-03-13
Q4 2020 $89.8M +$13.4M +17.5% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $76.5M +$22.4M +41.5% Dec 31, 2019 10-K 2021-03-15
Q4 2018 $54M +$18.7M +53.1% Dec 31, 2018 10-K 2020-03-11
Q4 2017 $35.3M +$19M +116% Dec 31, 2017 10-K 2019-03-07
Q4 2016 $16.3M +$10.2M +166% Dec 31, 2016 10-K 2018-03-29
Q4 2015 $6.14M Dec 31, 2015 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.